Zachary Hunter

Zachary Hunter is a Principal Scientist at Dana-Farber Cancer Institute, where responsibilities include serving as the associate director of the Bing Center for Waldenström's Macroglobulinemia and being the inaugural incumbent of the Tim and Ginny Bliss Investigatorship. Additionally, Zachary holds the position of Research Associate and Instructor of Medicine at Harvard Medical School. Previous roles include Clinical Research Coordinator focused on clinical trials for Bortezomib and Alemtuzumab, as well as managing research protocols related to familial Waldenström's Macroglobulinemia. Education includes a Ph.D. in Pathology and a Master's degree in Pathology/Experimental Pathology from Boston University, along with a Bachelor of Science in Mathematics from Haverford College. Prior to current roles, Zachary was self-employed as a private math tutor from 2000 to 2004.